Chloroquine-induced QTc prolongation in COVID-19 patients

BACKGROUND: In the battle against the SARS-CoV‑2 pandemic, chloroquine has emerged as a new potential therapeutic option for the treatment of infected patients. A safety consideration for the application of chloroquine is its QTc-prolonging potential. Thus far, no data are available on the QTc-prolo...

Descripción completa

Detalles Bibliográficos
Autores principales: van den Broek, M. P. H., Möhlmann, J. E., Abeln, B. G. S., Liebregts, M., van Dijk, V. F., van de Garde, E. M. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189353/
https://www.ncbi.nlm.nih.gov/pubmed/32350818
http://dx.doi.org/10.1007/s12471-020-01429-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189353/
https://www.ncbi.nlm.nih.gov/pubmed/32350818
http://dx.doi.org/10.1007/s12471-020-01429-7

Ejemplares similares